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The  Structure of Residues 7-16 of the Aa-Chain of Human Fibrinogen 
Bound to Bovine Thrombin at 2.3-A Resolution* 
(Received for publication, October 3,  1991) 
Philip D. Martin, William Robertson, Dusan Turk$, Robert Huber$, Wolfram  Bode$, and 
Brian F. P. Edwards8 
From the Department of Biochemistry,  Wayne State Uniuersity, Detroit, Michigan 48201 and the $Max-Planck-Institut fur 
Biochemie, 08033 Martinsried, Germany 
The tetradecapeptide Ac-D-F-L-A-E-G-G-G-V-R-G- 
P-R-V-OMe, which mimics residues 7f-20f of the Aa- 
chain of human fibrinogen, has been co-crystallized 
with bovine thrombin from ammonium sulfate solu- 
tions in space group PI1 with  unit-cell dimensions of 
a = 83.0 A, b = 89.4 A, c = 99.3 A, and /3 = 106.6‘. 
Three crystallographically independent complexes 
were located in  the  asymmetric  unit by molecular re- 
placement using the  native bovine thrombin structure 
as a model. T$e standard crystallographic  R-factor  is 
0.167 at 2.3-A resolution. Excellent electron density 
could be traced  for  the decapeptide, beginning  with 
Asp-7f and  ending  with Arg-16f in  the active  site of 
thrombin;  the  remaining 4 residues, which have been 
cleaved from the  tetradecapeptide at the Arg-lGf/Gly- 
17f bond, are not seen. Residues 7f - l l f  at the NH2 
terminus of the peptide form a single turn of a-helix 
that is connected by Gly-l2f, which has a positive d, 
angle, to an extended chain  containing  residues 13f- 
16f. The major specific interactions between the pep- 
tide  and  thrombin are 1) a hydrophobic cage formed 
by residues Tyr-GOA,  Trp-GOD, Leu-99,  Ile-174, Trp- 
216, Leu-Sf, Gly-l3f,  and Val-15f that  surrounds  Phe- 
8f;  2) a hydrogen bond linking  Phe-8f NH to  Lys-97 
0; 3) a salt link between Glu-llf and  Arg-173;  4)  two 
antiparallel &sheet hydrogen bonds between Gly-14f 
and Gly-216; and 6) the  insertion of Arg-16f into  the 
specificity pocket. Binding of the peptide is accom- 
panied by a considerable shift  in  two f the loops near 
the active site  relative  to  human D-phenyl-L-prolyl-L- 
arginyl chloromethyl ketone (PPACK)-thrombin. 
a-Thrombin (EC 3.4.21.5), is the product of prothrombin 
cleavage  by factor Xa  in  the final step of the blood clotting 
cascade. It is a very  specific serine protease that cleaves after 
a limited number of arginine (rarely lysine) bonds in  proteins. 
During clotting, thrombin  cuts the fibrinogen Aa-chain  and 
* This work  was supported in part by National Institutes of Health 
Grant GM 33192 and a  grant-in-aid from WSU Center for Molecular 
Biology (to B. E.) and by Sonder Forshungsbereich 207 grants (to R. 
H. and W. B). Prior to publication, coordinates and structure  factors 
will be deposited in the Brookhaven Protein Data Bank  for release 
in May, 1993. In  the interim, requests for the coordinates should be 
directed to B. E. The costs of publication of this article were defrayed 
in  part by the payment of page charges. This article  must therefore 
be hereby marked “aduertisement” in accordance with 18 U.S.C. 
Section 1734  solely to indicate this fact. 
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BB-chain at Arg-16f’ and Arg-14f, respectively. Except for a 
slow cleavage at Arg-19f in the Aa-chain (Blomback et al., 
1967), the other arginine and lysine bonds in the two chains 
of fibrinogen are unaffected. By contrast,  trypsin, which has 
a similar preference for lysyl and arginyl peptide bonds, 
cleaves fibrinogen into 100-150 fragments (Blomback et al., 
1967). Thrombin also has  a secondary binding site for fibrin- 
ogen that is remote from the active site (Noe et al., 1988). 
The bovine enzyme contains an A-chain of  49 residues (Mr = 
5721), which is not required for activity or specificity (Pirkle 
et al., 1989), linked via a disulfide bond to a  B-chain of 259 
residues (Mr = 29,683) at residues 1 and 122, respectively 
(Magnusson et al., 1975; MacGillivray and Davie, 1984). The 
B-chain contains  a carbohydrate chain at Asn-6OG and the 
active site residues His-57, Asp-102, and Ser-195. The  throm- 
bin residue numbers in this paper, which are assigned by 
homology with chymotrypsin (Bode et al., 1989), use upper- 
case letters for inserted residues. Bovine a-thrombin  has 32 
residues identical with human  a-thrombin  in  the A-chain and 
225 identical residues in the B-chain. Three-dimensional 
structures of human  thrombin complexed with PPACK’ 
(Bode et al., 1989) and with hirudin (Rydel et al., 1990; Grutter 
et al., 1990) have been published recently. A preliminary 
report of the fibrinopeptide structure discussed in this paper 
has appeared as  an abstract  (Martin et al., 1991). 
When  thrombin  reacts with fibrinogen, the first 16 residues 
of the Aa-chain of fibrinogen are released rapidly as fibrino- 
peptide A, followed  more  slowly  by fibrinopeptide B, which 
contains residues 1-14  of the BP-chain. The specific interac- 
tions that govern the binding of fibrinogen to the active site 
of thrombin have been explored in considerable detail by 
determining the conserved sequences in fibrinogen (reviewed 
by Henschen et al., 1983;  Mbnachb, 1983) and by active site 
mapping with synthetic analogs of fibrinopeptide A (reviewed 
by Blomback, 1986; Scheraga, 1986). These  studies have 
shown that  the first 6 residues of fibrinopeptide A do not 
interact with thrombin, whereas Asp“lf, Phe-8f, Gly-12f, and 
Arg-16f are required for maximum binding of the peptide to 
thrombin. 
Sequence numbers for fibrinopeptide residues are distinguished 
from those for thrombin residues by the suffix “E” The notation of 
Schechter and Berger (1967) has been used for the substrate residues 
and  their subsites on  thrombin, namely P, for substrate residues and 
S, for their corresponding enzyme subsites on the amino-terminal 
side of the scissile bond and P’, and S’, for the substrate residues 
and enzyme subsites, respectively, on the carboxyl side of the scissile 
bond. The scissile bond lies between the  PI  and P‘l residues. The 
three separate complexes in the asymmetric unit are numbered I, 11, 
and I11 and their components as fibrinopeptide I, 11, and 111 and 
thrombin I, 11, and 111. 
* The abbreviations used are: PPACK, D-phenyl-L-prolyl-t-arginyl 
chloromethyl ketone; Ac, acetyl; OMe, methoxy. 
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Since Asp-7f and  Phe-8f  are relatively far  in  sequence from 
the scissile bond a t  Arg-16f, several investigators  have  pro- 
posed that  the  amino-terminal  end of fibrinopeptide A binds 
to  thrombin  in a bent  configuration  with  Phe-8f close to Arg- 
16f (Blomback et al., 1969; Rae  and  Scheraga, 1979). Marsh 
et  al. (1983) proposed that this hairpin-like structure was 
stabilized by a salt  link between Asp-7f and Arg-19f. More 
recent  studies by Ni  et al. (1989a, 1989b), using high resolution 
NMR  techniques, have  suggested that residues Asp-7f through 
Glu-llf  are  in  an  a-helical  structure  that  is  stabilized by a 
backbone hydrogen bond between Asp-7f and  Glu-llf  and 
possibly also by another hydrogen bond between the side 
chain of Asp-7f and  the  NH  proton f Leu-Sf. Ni  et al. (1989b) 
also proposed that  this  turn of helix, together  with a multiple- 
turn  structure for  residues Glu-llf  to  Val-l5f, group the side 
chains of Phe-8f, Leu-Sf, and Val-15f into a hydrophobic 
cluster that is a key determinant of the interaction with 
thrombin. 
The crystallographic structure  presented  in  this  paper of 
the complex between bovine thrombin  and  the  decapeptide 
Ac-D-F-L-A-E-G-G-G-V-R, which contains residues 7f-16f 
of the fibrinogen Aa  chain,  has completely  defined the  struc- 
ture of the  bound  peptide  and  delineated  subsites S9 to SI on 
thrombin.  The  peptide  has  the  a-helical  turn  and hydrophobic 
cluster observed  by  Ni et al. (1989b) but  differs  significantly 
in the backbone structure for residues Gly-12f to Arg-16f, 
which are poorly defined by the  NMR  data. 
MATERIALS AND  METHODS 
Preparation of Bouine Thrombin-The enzyme was prepared as 
described previously (Martin  et al.,  1983) and  had  approximately 2000 
NIH clotting units/mg of protein. I t  was stored at -20 "C as a 
precipitate  in  ammonium  sulfate before  being set  up for crystalliza- 
tion. The synthetic peptide Ac-D-F-L-A-E-G-G-G-V-R-G-P-R-V- 
OMe  (peptide  F8 of Ni  et al., 1989a), containing residues 7f-20f of 
the  An-chain of human fibrinogen or residues P g  to Pf4 in  the  notation 
of Schechter and Berger (1967), was a gift from Harold Scheraga 
Department of Chemistry,  Cornell  University,  Ithaca, NY. 
Crystallization-Crystals of the thrombin/peptide complex were 
grown by mixing  a  5:l molar  ratio of peptide  to  protein a t   pH 8.0 and 
setting  the  resulting  mixture  up for crystallization  in 20 pl of hanging 
drops on silanized coverslips inverted over wells containing 40% 
ammonium  sulfate  as  the  precipitant. The  crystals  belong  toespace 
group p2 ,  with unit cell dimensions a = 83.02 A, b = 89.41 A, c = 
99.30 A, @ = 106.64", with  three  separate complexes of bovine throm- 
bin  and  the  fibrinopeptide  in  the  asymmetric  unit. Polyacrylamide 
electrophoresis (Laemmli, 1970)  showed that approximately  one-half 
of the a-thrombin had converted to the @-, c-, and y-proteolytic 
derivatives during  crystallization (Fig. 1; Edwards et  al., 1986). Data 
were collected on two crystals taken from the same crystallization 
well using a Siemens  area  detector  with a Rigaku RU2OOH rotating 
anode x-ray  source and  Supper  graphite  monochromator  operated a t  
40 kV and 70 mA. Crystals were mounted  in  quartz  capillaries  without 
regard to  orientation.  Three "sweeps," each of which  covered 110" in 
w with 440 frames of data, were collected  for each  crystal;  the q5 angle 
was  incremented by 70" between sweeps. Each  data  frame  was col- 
lected for 3-4 min to  ensure  that  it  contained  at  least 2 million total 
counts.  The  data were merged and scaled with  XENGEN  (Howard 
et  al., 1987)  yielding 176,974 reflectioas  with  I/a > 1.0 of which 47,459 
were unique between 7.0 and 2.3 A. These data, which represent 
78.9%  of the possible  reflections, had  an overall unweighted  absolute 
R,, of 0.075. The  fraction of observed reflections for the  shells m- 
7.0, 7.0-3.0, 3.0-2.5,  2.5-2.4, and 2.4-2.3 A were, respectively, 95, 95, 
77,59,  and 39%. 
Molecular Replacement-The structure was solved by the molecular 
replacement  method  (Rossman  and Blow, 1962) using  the  MERLOT 
programs (Fitzgerald, 1988) with a previously determined  structure 
of free  bovine thrombin  as  the model. Details of the model structure, 
which  was solved in space  group P21212 using  the  structure of human 
thrombin  (Bode  et al., 1989), will be presented elsewhere.  A moleculab 
transform was computed by placing the model structure  in a 120-A 
P1 orthogonal unit cell. Rotation  functions were first  calculated  with 
the  fast  rotation  function program CROSUM  (Crowther, 1972), using 
A B  
FIG. 1. Polyacrylamide gel electrophoresis of the thrombin 
crystal .  A crystal of the  fibrinopeptide complex used for data collec- 
tion was  dissolved in 1% sodium dodecyl sulfate  sample  solution  and 
analyzed  in  lane A on a 17% acrylamide gel under reducing conditions 
(Laemmili,  1970). Lane B shows a crystal of a-thrombin complexed 
with hirudin. A proteolytic cut a t  Arg-77A converts the intact B- 
chain (116-S247, 259 residues),  labeled as B123 in  the figure, which 
is  unique to  a-thrombin,  into  fragment  B1 (I16-R77A, 73 residues) 
and  fragment  B23 (K78-S247, 186 residues), which is  unique  to @- 
thrombin; a proteolytic  cut a t  Thr-149A  converts  the  intact B-chain 
into  fragment B12 (I16-T149A, 150  residues),  which is  unique  to c- 
thrombin,  and  fragment  B3 (S149B-S247,109 residues),  and  cuts a t  
both Arg-77A and  Thr-149A  convert  the  intact  B-chain  into  fragment 
B1, fragment B2 (K78-T149A, 77 residues), which is unique to y- 
thrombin,  and  fragment B3." Fragment  B1  exhibits  an anomalously 
high  molecular  weight,  because it  carries  the polysaccharide chain a t  
Asn-6OG. 
an  increment of 2.5" for a, an  increment of 5" for p and y, 4a  data 
between  7 and 3 A, and a radius of integration of 17 A. The calcula- 
tions were repeated  around  the  major  peaks with LATSUM  (Lattman 
and Love, 1970) using an  increment of 1" for all angles and 40% of 
the  highest  data between  7 and 4 A. Translation  functions  (Croyther 
and Blow, 1967; Tollin  et al.,  1966) were calculated a t  7.0-3.5 A  for 
the entire unit cell in fractions of 0.02 of a unit cell. The three 
solutions  from  the  translation  function were  refined by rigid body R- 
factor  search with RMINIM  (Ward  et al., 1975) a t  7.0-3.5  A. 
Structure Analysis-Positions  for  hydrogens were determined with 
CHARMM2l  and were  used to estimate hydrogen  Pond angles. Our 
criteria for  hydrogen bonds were a distance of  3.35 A or less between 
the  non-hydrogen  donor  andacceptor  atoms for  a standard hydrogen 
bond, a distance of 3.35-3.5 A or less  for a "long" hydrogen  bond and 
an angle of 110" or greater for the  donor-H.. .acceptor atoms (Vino- 
gradov, 1980; Wlodawer and Sjolin,  1983). Surface  areas were calcu- 
lated  according to Connolly  (1983) in  QYANTA using  a  surface point 
density of 5.0 and a probe  radius of 1.7 A. 
RESULTS 
Structure  Solution  and Refinement-The rotation  and 
translation  solutions  are  listed  in  Tables I and 11. Numerous 
other rotation function peaks, all of which failed to give 
a result  in  the  translation  functiop, appeare! ate60-70% of 
the  maximum  peak  height when  7 A-5 A or 7 A-4 A data were 
used. Translation  functions were also calculated for several 
peaks that were smaller  than  those listed in Table I in  an 
attempt  to  find a putative fourth molecule, but only noise 
peaks  appeared  in  the maps. The rigid body refinement with 
RMINIM reduced the  R-factor from 0.464 to 0.398. 
The  first  14 cycles of restrained,  least  squares  refinement 
with PROFFT (Hendrickson and Konnert, 1979; Aganvcl 
1978; Finzel  19t7)  dropped  the  R-factor from 0.378 at 3.0 A 
to 0.294 at 2.3 A. A 2F0 - F, electron  density  map revealed 
' R. Kunjummen, V. Kumar, W. D. Robertson, P. D. Martin,  and 
B. F. P. Edwards,  manuscript  in  preparation. 
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TABLE I 





















Angles Root mean square units 
a P y Height t2z 
153.75 92.20 166.72  6.4  2.2 
153.31 92.86 164.03 
154.31 91.61 165.83 
29.25 95.16 274.95  6.3  2.1 
29.97 95.30 275.70 
29.71 95.70 276.40 
29.14 86.11 167.53  5.2  1.0 
31.17 86.05 167.67 
27.92 87.75 168.68 
TABLE I1 
Translation function results 
Calculated with 40 data in the range 7-3.5 A. 
Molecule U V W Height" Nextb 
1' 0.90 0.50 0.12  12.6  5.9 
2' 0.08 0.50 0.98  21.3  4.9 
3' 0.92 0.50 0.82  10.9  5.9 
1 us 2d 0.42 0.72 0.08  16.0 5.5 
1 us 3d 0.50 0.90 0.66  11.2  4.4 
2 us 3d 0.08 0.18 0.58  3.9  4.6 
1' 0.047 0.250 0.436 
2' 0.460 0.973 0.510 
3' 0.541 0.149 0.090 
Peak height expressed as the number of u above the mean. In 
every case, the peaks in  this column were the highest peaks in the 
map. 
*The next highest peak expressed as the number  of u above the 
mean. 
Self vector calculated by TRNSUM in MERLOT. 
Cross-vector calculated by TRNSUM  in MERLOT. 
e Calculated with RMINIM, values given are x ,  y, 2. 
density in the active sites of all three complexes in the 
asymmetric unit.  Alternate cycles of refinement followed by 
graphics intervention allowed us to fit the  entire sequence 
Ac-D-F-L-A-E-G-G-G-V-R-COO in all  three molecules. After 
a total of 48 cycles, the R-factor was  0.246 with  root mean 
square deviations for bonds and w angles of 0.022 A and 1.7", 
respectively. Water molecules were then added at positions 
that were within 2.5-3.5 A of a hydrogen-bonding donor or 
acceptor and had electron density in  both F,, - F, and 2F, - 
F, maps. A total of  97 cycles of PROFFT refinement dropped 
the R-factor to 0.199 at 7.0-2.3-A resolution. At this  point, 
the three  thrombin molecules  were refit manually and  further 
refined with EREF  (Jack  and Levitt, 1978) to  an R-factor of 
0.174 with a root mean square of  0.016 on bonds and 9.2" on 
o angles, which are  not  restrained  in  EREF.  Electron density 
maps phased with this model revealed a new trace for the 
145-150  loop in  thrombin I that placed Thr-149A and  Ser- 
149B 15 A apart.  Continuing the refinement with PROFFT 
to  cycle 188 reduced the R-factor to 0.172 (Tables I11 and IV). 
Additionally, the final 15 cycles of refinement used the values 
for AFSIG and BFSIG suggested by the program. This pro- 
duced a UA plot (Read, 1986) that placed a  least  squares  line 
through the origin, giving an estimate for the mean error of 
the structure of 0.25 A. Other weighting schemes gave slightly 
lower R values, but produced uA plots that did not go through 
the origin and  had worse estimates for the mean error. 
Throughout the refinement, fibrinopeptide I had  a higher 
average temperature fact?r than either peptide I1 or I11 (50 
A' versus 27 and 19 A', respectively). Moreover, Arg-16f 
in peptide I had  a higher average temperature factor than  the 
same residue in fibrinopeptides I1 or I11 (40 A2 uersus 13  and 
TABLE I11 
Refinement statistics from PROFFT 
Total number of atoms 8,084 
Number of solvent atoms 706 
Number of observations 47,459 
Mean isotropic B (A') 33.5 
Root mean square deviations 
Bond distances (A) 0.020 
Angle distanceso (A) 0.037 
1-4 distances (A) 0.037 
Bond angles (degree:) 1.1 
915 peptide planes (Ab 0.0107 
111 aromatic planes (A) 0.0087 
Chiral volume (A3) 0.141 
single torsion contacts (A) 0.213 
Multiple torsion contacts (A) 0.313 
Possible (X . . . Y) H bond contacts (A) 0.305 
Planar (w) torsion angles (degrees) 3.3 
Staggered torsion angles (degrees) 21.6 
Orthonormal torsion angles (degrees) 27.4 
Final R-factor from PROFFT 0.172 
R-factor from XPLOR (B refinement only) 0.167 
TABLE IV 
Final R-factors  from PROFFT as a function of resolution 
Dm,, Reflections Shell Sphere 
A 
6.0  1,306  0.234  0.234 
4.0  8,320  0.148  0.157 
3.5  5,693  0.143  0.152 
3.0 9,656  .170  0.157 
2.5  15,792  0.200  0.168 
2.4  3,730 0.211 0.170 
2.3  2,962  0.220  0.172 
16 A', respectively), although it was tightly constrained in the 
specificity pocket and  pinned by the same H bonds and  salt 
links. Consequently, we used the XPLOR program (Briinger, 
1988) to refine only the B values of the  three complexes  while 
successively  lowering the occupancy of fibrinopeptide I from 
1.0 to 0.4 in 0.1 increments. Fifteen cycles of temperature 
factor optimization were done at each occupancy value using 
target us of 1.5 (backbone) and 2.0 (side chain) for 1-2 B 
factor pairs  and 2.0 (backbone) and 2.5 (side chain) for 1-3 
angle B-factor pairs. At  occupancy values of 0.7,0.6, and 0.5, 
the averageFemperature factor of  Arg-16f in peptide I was  21, 
16, and 13 A', respectively. An occupancy of  0.6,  which  made 
the average temperature factor of Arg-16f in fibrinopeptide I 
similar to  that  in fibrinopeptide 111, was used for the final 
model, which had an R-factor of  0.167. At lower occupancies, 
some of the atoms in Arg-16f  of fibrinopeptide I had  anoma- 
lously low temperature factors. 
Structure of Bovine Thrombin-The three models of bovine 
thrombin include residues 1H through 247; there is no electron 
density for the first 13 residues at  the amino terminus of the 
A-chain. The single carbohydrate  chain at Asn-GOG, which is 
completely open to solvent in all three  structures, also lacks 
convincing density and has been left out. When human 
PPACK-thrombin (Bode et al., 1989) and bovine thrombin 
molecule I11 are superimposed by a  least squares calculation 
(Rossman and Argos, 1975), the root mean square difference 
between C, atoms is 0.41 for 245 coincident residues. The 51 
residues which are  structurally different include the regions 
that are  not well defined in the electron density maps such as 
the  termini of the A chain  and the carboxyl terminus of the 
B chain. There were  some movements of well defined parts 
of the structure that were greater than 1 A relative to human 
PPACK-thrombin, but in all cases they are explained by 
intermolecular contacts between symmetry related molecules 
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or by interactions with the fibrinopeptide, or both. 
Two chain displacements relative to human thrombin  are 
particularly cogent. The YPPW loop centered at  Trp-GOD 
has moved  by  0.6 A in molecule I and 1.4 A in molecules I1 
and 111 to more fully cover the Val-15f side chain. Part of 
these  perturbations  are due to intermolecular contacts  in this 
region, but we believe that  the presence of the entire fibrino- 
peptide in the active site  exerts an additional force to more 
fully enclose the active site with this loop. The C, atom of 
Lys-97 moves 1.5 A in all  three  thrombin molecules to make 
the backbone hydrogen bond between Lys-97 and Phe-1Of. 
This portion of all  three molecules is open to solvent and  not 
near  any symmetry related molecules. 
There  are 43 differences between the human  and bovine 
thrombin sequences, most of which are  on  the surface of the 
molecule. Some of these  sites differ by  more than  the overall 
root mean square deviation between the two structures  but 
they all fall in mobile  poorly defined sections of the map or 
are involved in intermolecular or fibrinopeptide contacts. The 
only residue in direct contact with the fibrinopeptide that 
differs between bovine and  human thrombin is Lys-97, which 
FIG. 2. Electron density and 
model for the fibrinopeptide. The 
electron density in a 2F. - F, map con- 
toured at 1.5 u by the program CHAIN 
is shown  in stereo for residues 7f-llf ( A )  
and residues 12f-16f ( B )  of the fibrino- 
peptide bound to thrombin molecule 111. 
The final refined model is shown in thick 
lines. Thrombin residues have been 
omitted for clarity. 
is arginine in human  thrombin. 
Structure of the Bound Peptides-Our electron density 
maps, which  show no density following  Arg-16f in  the speci- 
ficity pocket for any of the  three crystallographically inde- 
pendent peptide structures, confirm that thrombin cleaves 
the substrate peptide at  the Arg-16f/Gly-l7f bond (Ni et al., 
1989a). The structure of the 10 residues 7f-16f bound to 
thrombin  can be described as one turn of helix, composed of 
residues Asp-7f to  Glu-llf (Fig. %I), linked via Gly-l2f  and a 
type I p bend involving residues 9f-l2f, to  an extended chain 
composed of Gly-13f to Arg-16f (Fig. 2B). The backbone 
hydrogen bonds (Fig. 3)  and main chain torsion angles (Fig. 
4) are similar in all three fibrinopeptides. The root mean 
square deviation in C, positions are 0.37, 0.44, and 0.29 A, 
respectively, between fibrinopeptides I and 11, I and 111, and 
TI and 111. 
Thrombin Subsites-The five principal interactions that 
bind the peptide to thrombin (Fig. 5)  are (1) a hydrophobic 
cage surrounding Phe-8f (Fig. 6),  (2) a hydrogen bond linking 
Phe-Sf NH  to Lys-97 0, (3) a salt link between Glu-llf  and 
Arg-173 (Table V), (4) two antiparallel &sheet hydrogen 
7f 7f 
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FIG. 3. Intrapeptide backbone hydrogen bonds.  The backbone hydrogen bonding is slightly  different among 
the three fibrinopeptides (molecule I is c-thrombin, molecules I1 and 111 are a-thrombin). The solid lines are 
hydrogen bonds between 2.5 and 3.35 A long; the dashed lines represent bonds that are 3.35-3.5 A long. 
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FIG. 4. Main-chain torsion  angles for the  three fibrinopep- 
tide molecules.  The 6 (abscissa) and $ (ordinate) angles for fibri- 
nopeptides I (O), I1 (O), and 111 (A) are shown relative to the allowed 
regions.  The  markers for Gly-12f are shaded. 
7 
s1-G219 
FIG. 5. Thrombin-fibrinopeptide interactions. The interac- 
tions are shown schematically for subsites Sl-S9 on thrombin. Arrows 
indicate  hydrogen  bonds from donor to  acceptor  atom. 
bonds between Gly-14f and Gly-216, and (5) the insertion of 
Arg-16f into the specificity pocket (Table V). The subsites 
may be cataloged as follows. 
Sl/Arg-lGf-The side chain of Arg-16f is bound in the 
specificity pocket via a salt bridge to  the carboxyl group of 
Asp-189 and a hydrogen bond to  the carbonyl oxygen  of  Gly- 
219. The mainchain NH atom of Arg-16f makes a hydrogen 
bond with the carbonyl oxygen of Ser-214, whereas the car- 
boxyl-terminal oxygen atoms of Arg-16f interact with the 
main chain NH atoms of Gly-193, and Ser-195, the imidazole 
ring of His-57, and  the OG atom of Ser-195. 
S2/Val-l5f"This residue, which is part of the hydrophobic 
cage surrounding  Phe-8,  is andwiched between Trp-GOD and 
Leu-99. 
S3/Gly-14f-This subsite involves two antiparallel B-sheet 
hydrogen bonds between Gly  14f and Gly-216. 
S4/Gly-13f-There is no S4 subsite on bovine thrombin. 
Gly-13f interacts only with the carbonyl oxygen of Phe-8f and 
solvent molecules. 
S5/Gly-l2f"There is no 5 5  subsite on bovine thrombin. 
Gly-12f interacts only with solvent. 
SG/Glu-llf-There is a salt bridge formed between the side 
chain carboxyl group of Glu-llf and the guanidinium group 
of Arg-173. 
S7/AlalOf--This residue does not  interact with thrombin. 
S8/Leu-Sf-Leu-Sf,  which is part of the hydrophobic cage 
around Phe-8f, is close to Tyr-GOA, but is only partially buried, 
unlike the  other hydrophobic groups of the peptide. 
SSIPhe-8f-The side chain of Phe-8f is enclosed in a hy- 
drophobic cage (Fig. 6) formed by 4 thrombin residues, namely 
Tyr-GOA, Leu-99, Ile-174, and Trp-215, which  form the "apo- 
lar binding site" of thrombin (Berliner and  Shen, 1977; Bing 
et al., 1981; Sonder and  Fenton, 1984) and 3 fibrinopeptide 
residues, namely Leu-Sf,  Gly-13f, and Val-15f. The aromatic 
ring of Phe-8f is perpendicular to  that of Trp-215, an orien- 
tation which has been observed in other  proteins (Burley and 
Petsko, 1985). 
SlO/Asp-7f-There is no interaction between Asp-7f and 
thrombin in any of the  three complexes in the asymmetric 
unit. In fibrinopeptides I1 and 111, the side chain carboxyl 
group makes a hydrogen bond with the NH of  Ala-1Of. 
The surface area that is buried when a substrate or inhibitor 
binds an enzyme is an approximate measure of the contribu- 
tion of Van der Waals enthalpy  and the entropy from released 
solvent molecules to  the binding constant (Chothia, 1974). 
The surface area buried by the interaction between thrombin 




FIG. 6. The hydrophobic cage for 
Phe-8f. The orientation of the 7 hydro- 
phobic residues that surround  Phe-8f are 
shown in stereo for thrombin molecule 
111. 
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TABLE V 
PeptidelThrombin ionic interactions 
Distance 
Peptide Atom Thrombin residue residue  Molecule  ol cule  Molecule 
1 2 3 
A 
Glu-llf  OEl Arg-173 NE 2.85  3.44 
Glu-llf OE2 Arg-173 NH2 3.48 
Arg-16f NH1 Asp-189 OD2 3.27  2.89  3.19 
Arg-16f NH2 Asp-189 OD1 3.17  2.52  2.86 
Arg-16f NH2 Gly-219 0 3.13  3.07  3.08 
Arg-16f 0 Ser-195 N 3.14  3.12  3.20 
Arg-16f 0 Gly-193 N 2.78  2.99  2.73 
Arg-16f OT His-57  NE2 3.10  2.78  2.51 
Arg-16f OT Ser-195 OG 2.82  2.40' 
Glu-llf OE2 Lys-109" NZ 2.82 
On a symmetry-related molecule. 
* This  short distance is due to  the inability of PROFFT  to handle 
the situation in which multiple positioning of a pair of adjacent atoms 
produces essentially constant electron  density between them. 
and  the 10 residues of the fibrinopeptide is 893 A', which is 
comparable with the 1022 A' buried in  the interaction between 
trypsin and the 14 residues of bovine pancreatic trypsin 
inhibitor that actually contact trypsin (Ruehlmann et aZ., 
1973; Janin  and Chothia, 1976; Huber  and Bode,  1978). 
DISCUSSION 
Structure of the Thrombin Molecules-Although the  three 
thrombin molecules in the asymmetric unit are crystallo- 
graphically independent, they have very similar structures, as 
evidenced by the small root mean square deviations in C, 
positions, which are 0.29,0.30, and 0.32, respectively, between 
molecules I and 11, I  and 111, and I1 and 111, as determined by 
program ALIGN (Cohen et al., 1981) for 270 pairs of residues. 
Molecules I  and I1 are related to one another by a  rotation of 
116" on an axis almost parallel to  the crystallographic z axis 
and molecules I and I11 by a rotation of 126" on an axis almost 
coincident with the y axis. Molecules  I1 and 111, however, are 
related by a local %fold (178") which is roughly in  the xy 
plane. Local differences larger than 0.5 A occur only for C, 
atoms of residues close to intermolecular contacts. 
Residues in the flexible insertion loop 145-150, which have 
high temperature factors and noncontinuous density, exhibit 
the largest differences between thrombin molecules. In  throm- 
bin molecule I, the electron density  has been interpreted such 
that  the C, atoms of Thr-149A and Ser-149B are 15 A apart, 
which identifies molecule I as predominantly t-thrombin. Trp- 
148 in molecule I, which has  strong well defined density, is 
tightly packed between the same loop in molecule I1 and  the 
region about residues Ile-16 and Gln-239 in a symmetry mate 
of molecule 11. In  thrombin molecules I1 and 111, the electron 
density for the mainchain atoms is well-defined for all the 
loop residues except 149A,  149B, and 149C in molecule I1 and 
148 through 149C in molecule 111. We have assumed that 
molecules I1 and I11 are primarily a-thrombin and fit this 
region with a closed  loop, because polyacrylamide gel electro- 
phoresis indicates that  the crystals are approximately one- 
half a-thrombin (Fig. l), and because, in contrast to thrombin 
molecule I, the gap in the electron density can be spanned by 
the indeterminate residues. The similarity of thrombin  I to 
thrombin molecules I1 and I11 everywhere but at  the insertion 
loop 145-150 agrees with the observation that €-thrombin, 
which has been specifically generated by elastase digestion of 
a-thrombin  (Kawabata et al., 1985), has approximately 60% 
of the clotting activity and essentially 100% of the esterase 
and amidase activity of a-thrombin (Brower et al., 1987; 
Hofsteenge et al., 1988; Brezniak et al., 1990). 
Some @- and  y-thrombin, which have a chain break between 
Arg-77A and Lys-78, are also present  in the crystals, albeit at 
lower concentrations than a- or t-thrombin (Fig. 1). There  is 
no evidence for a  chain break at this position in the electron 
density of thrombin molecules I and 11. The main chain 
electron density for these 2 residues is weaker in thrombin I11 
but  still continuous at  the peptide bond, although there  is  a 
gap at  the amide nitrogen of Arg-77A. We have fit this region 
in thrombin I11 as an intact loop, that is, as a-thrombin, 
because it gave the best fit for the existing density. 
Structure of the Fibrinopeptide Molecules-Like the throm- 
bin molecules, the  three bound peptides in the asymmetric 
unit  are very similar  in  their overall structure,  but do exhibit 
some differences. All three peptides have the hydrogen bond 
linking the amide nitrogen of Glu-llf  to  the carbonyl oxygen 
of  Asp-7f as reported for the structure determined by NMR 
(Ni et al., 1989a, 1989b), but we do not see the backbone 
hydrogen bond from Gly-13f to Ala-lOf  which defines a type 
I1 @-turn  in  the NMR structure.  Instead, we see a hydrogen 
bond from Gly-12f to Leu-Sf in a type I  @-turn. Also, the side 
chain carboxyl group of Asp-7f is hydrogen-bonded to  the 
amide of Ala-lOf, not Leu-Sf as proposed by Ni et al. (1989b). 
We also see five other  intrapeptide hydrogen bonds in one or 
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more of the  three fibrinopeptide structures (Fig. 3). Two of 
these hydrogen bonds, namely AlOf + D7f and El l f  - F8f 
also define type I  fl-turns. Residues Gly-14f and Val-15f are 
in  an extended conformation in  the x-ray structures,  not  a 
type 11' 0-turn  as reported in the NMR structure (Ni et al., 
1989b;  Fig. 7). In  the NMR  structure calculations, the back- 
bone structure of these residues varied considerably due to 
limited  data  and  a resonance overlap between Gly-13 and Gly- 
14 (Ni et al., 1989b). 
The temperature factors for the main chain  atoms of the 
three peptides indicated th$ peptide I, which had an average 
temperature factor of 50 A', was either disordered or only 
partially bound relative to peptides I1 and 111. The latter 
explanation was supported by the fact that  the electron den- 
sity for peptide I was  well defined, albeit somewhat weaker 
than for the other peptides. The discrepancy between the 
density map and  the calculated temperature  factors was most 
striking for Arg-16f ia  peptide I, which had  an average tem- 
perature factor of 40 A' when an occupancy of 1.0  was used. 
An occupancy of 0.6 reduced the average temperature factor 
for the entire peptide I and its Arg-16f residue to values 
comparable with those of the other two peptides. In  the final 
refinement, the average temperature  factors for all  atoms in 
peptides I, 11, and I11 were 30,27,  and 19 A', respectively. The 
average temperature factors for the main chain atoms of 
thrombin molecules I, 11, and 111 were 32, 26, and 39 k, 
respectively. In  the discussion that follows, we have taken 
complex I11 as  the model because it  has  the lowest temperature 
factors for the fibrinopeptide residues. 
ThrombinlFibrinopeptide Interactions-As seen in Fig. 8, 
the  Pl-P3 residues of the fibrinopeptide overlap closely with 
the three residues of PPACK  in the structure of human a- 
thrombin (Bode et d., 1989) and consequently have many of 
the same interactions with subsites S1-S3. In both  structures 
the guanidino group forms a salt link with Asp-186 and a 
hydrogen bond with the carbonyl oxygen of Gly-219. Arg-16f 
has additional interactions with Gly-193, Ser-195, and  His- 
57, thanks  to  its free carboxyl group, whereas the arginine in 
PPACK is covalently linked to His-57 and Ser-195. The P2 
residue in both complexes, valine in the fibrinopeptide and 
proline in PPACK, form part of the hydrophobic cluster that 
surrounds  their respective phenylalanine groups. The  P3 res- 
idue in  both complexes forms an antiparallel  0-sheet  structure 
with Gly-216. In the fibrinopeptide, these two  hydrogen bonds 
pin one end of the 3 extended glycine residues which  have  no 
other specific interactions with thrombin. In the PPACK 
structure the two hydrogen bonds are augmented by the 
hydrophobic interactions of the D-phenylalanine side chain. 
Antiparallel 0-sheet hydrogen bonds are often involved in the 
interaction of serine proteases with peptide ligands or inhib- 
itors (Polgar, 1989 and references therein; Bode and Huber, 
1991). 
The fact that Gly-12f has  torsion angles that are energeti- 
cally costly for amino acids with a Cp atom explains why 
glycine is highly conserved in the P5 position. Fibrinogen 
Rouen, which has  a valine in the  P5 position, is cleaved  more 
slowly by thrombin  (Henschen et al., 1983; MBnachC?, 1983, 
Ni  et al., 1989b). Using NMR  data,  Ni  et al. (1989a) reported 
that Gly-12f is involved in  a type I1 @-turn and, along with 
Gly-l3f,  has  a positive r#~ torsion angle when the fibrinopeptide 
was bound to thrombin.  They  further showed that  the G12fV 
substitution changed the intrapeptide hydrogen bonds and 
displaced Gly-l4f relative to Phe-8f (Ni et al., 1989~). Our 
work  shows that Gly-12f is actually part of a type I 0-turn 
but does confirm a positive q5 torsion angle for Gly-12f. 
However,  Gly-13f  does not have the positive r#J torsion angle 
as reported by Ni et al. (1989b). 
The  salt bridge between the side chain of Glu-llf in position 
P6  and  the guanidinium group of Arg-173 on thrombin is a 
previously unsuspected interaction.  When  Marsh et al. (1983) 
added the 3 residues AlOf-Ellf-G12f to a  synthetic fibrino- 
peptide, the binding constant with thrombin was actually 
reduced. In our structure, the alanine in P7  and glycine in P5 
have no  specific repulsive or attractive interactions with 
thrombin  other than Van der Waals contacts. Evidently, the 
favorable interaction between Glu-llf and Arg-173 is not 
strong enough to overcome the entropic effects of adding 3 
additional residues which must be part of a turn to bind 
optimally but lack the intrapeptide interactions needed to 
stabilize that  turn. When the  turn is completed by adding the 
FIG. 7. Comparison of the fibri- 
nopeptide structures determined by 
NMR and x-ray crystallography. 
The structure of the fibrinopeptide 
bound to thrombin molecule Il l  is drawn 
in stereo with thick  lines. The structure 
of the fibrinopeptide hound to thrombin 
as determined by NMR methods (Ni et 
al., 1989) is shown in thin lines. The two 
structures were overlapped using the 
main chain coordinates for residues 7f- 
1 If. 
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FIG. 8. Comparison of the fibri- 
nopeptide and PPACK structures. 
The  structure of the  fibrinopeptide 
bound to thrombin molecule 111 is  drawn 
in stereo  with thick lines. The  structure 
of the  PPACK residue bound to human 
thrombin is shown by thin lines. The 
coordinates of PPACK-inhibited  human 
thrombin were overlapped with  those of 
bovine thrombin molecule 111. 
15f 
16f 
residues in positions P8 (Leu-Sf) and  P9 (Phe-Bf), the binding 
constant improves by a  factor of 2.3, the catalytic rate by a 
factor of  36, and as a consequence, the specificity constant by 
a factor of 83 (Marsh et al., 1983). The fact that Glu-llf 
is strongly conserved among mammalian fibrinogens, 
(Henschen et al., 1983; Southern, 1988; Table VI) suggests 
that  this  salt link is an  important factor in the productive 
binding of fibrinogen to  thrombin in most species but  it is 
not  an absolute requirement in  the same way that Gly-12 is. 
Phe-8f at position P9, which is widely conserved in nature 
(Blomback, 1967; Henschen et al., 1983), is responsible for 
most of the increased binding (Marsh et al., 1983). Its main 
chain carbonyl atom makes the key hydrogen bond that 
stabilizes the a-helical loop at  the amino-terminal end of the 
bound fibrinopeptide (Fig. 3),  its amide NH makes a strong 
hydrogen bond to the carbonyl of Lys-97 (Fig. 5), and its 
phenyl ring anchors  a large hydrophobic cluster that includes 
residues from both the peptide and from thrombin (Fig. 6). 
This hydrophobic cage, which completely encloses Phe-8f, 
contributes greatly to thrombin’s specificity toward fibrino- 
gen, since it is not accessible in  the native structure4 without 
a considerable movement of the insertion loop containing 
Tyr-GOA. In human  PPACK-thrombin, the phenyl  ring of D- 
Phe in position P3, which occupies the same site as Phe-8f  in 
the fibrinopeptide complex, but  enters  the  site from the op- 
posite direction (Fig. 8), is partially covered by the insertion 
loop (43 Az accessible to solvent). The binding of Phe-8f also 
pulls the exposed loop containing Trp-96  and Lys-97 toward 
the fibrinopeptide-Trp-96  clusters with Pro-GOB and Pro-GOC, 
whereas the carbonyl of Lys-97 makes a hydrogen bond with 
the  NH of Phe-8f. 
The role of the Asp-7f side chain at  position P10 is not  as 
obvious as  that of Phe-8f at  P9, although fibrinogen Lille, 
which has  asparagine at  the P10 position, clots slowly (Morris 
et al., 1981), and adding aspartic acid to a synthetic fibrino- 
peptide increases the specificity constant by a factor of 3 
(Marsh et al., 1983). Asp-7f has no direct  interactions with 
thrombin  in any of the  three complexes, although  rotation of 
the side chain of Lys-97, which is an arginine in human 
4 P .  D. Martin, R. Kunjummen, V. Kumar, W. Bode, R. Huber, 
and B. F. P. Edwards,  manuscript  in  preparation. 
thrombin, would allow a salt link with the Asp-7f carboxyl 
group. Instead, the side chain of Asp-7f hydrogen bonds to 
the amide of Ala-lOf, whereas the main chain carbonyl makes 
a hydrogen bond with the amide nitrogen of Glu-llf. To- 
gether,  these two interactions stabilize the helical turn  and 
thus facilitate  binding of the fibrinopeptide to thrombin. 
Almost all of the known sequences that are homologous to 
human fibrinopeptide A  (Table VI) can be accommodated by 
our structure without invoking any species-specific changes 
in the  thrombin molecule. The most common substitution at  
position PI0 is glutamic acid, which can  salt-link with Lys- 
97 as easily as  the aspartic acid in the human sequence. The 
position is also exposed enough to accept threonine and serine. 
Phenylalanine at  P9 is conserved in all species but  the  pron- 
ghorn antelope. Position P8 is occupied by a hydrophobic 
residue in all species but  the guinea pig. Position  P7, which 
has  the most exposure to solvent, also has the most substitu- 
tions. Glutamic acid at  P6, which binds with Arg-173 in our 
structure, is strongly conserved, with alanine appearing in 
three species and  aspartic acid in one. Position  P5, which can 
only accept glycine in  our structure,  has glycine present  in 
every species but the pronghorn antelope and the lizard. 
Glycine at  P4, which has torsion angles available to other 
amino acids but no exposure to solvent, is strongly conserved, 
with substitution by alanine  in only three specie!. An alanine 
Cs atom at  this position in our structure is 2.50 A from a ring 
atom of Phe-8f. These  three species all have a complementary 
replacement of Val-15f by glycine that provides the space for 
the phenylalanine  ring to relieve thc close contact with Ala- 
13f. The glycine at  P3, which has torsion angles available to 
other amino acids and significant exposure to solvent, is still 
strongly conserved but is replaced by larger amino acids in 
four species. The valine at  P2, which is part of the hydropho- 
bic cage around Phe-8f in our structure, is replaced only by 
isoleucine or smaller hydrophic residues. 
Of all the sequences listed  in  Table VI, only those for  the 
pronghorn, lizard, and lamprey are incompatible with our 
structure. With a serine at position P9  and a threonine at  
position P5  as listed in the Swiss Protein  Data Bank (entry 
FIBA$ANTAM), the pronghorn fibrinopeptide A cannot form 
the hydrophobic cage nor bend its amino terminus back 
Structure of Fibrinopepl 
TABLE VI 
Fibrinopeptide A sequences for positions PI0 through P I  
Sequences taken from Swiss Protein Data Bank, release 18, Protein 
Identification Resource Data Bank, release 28, Furlan (1988) and 
Ebert (1991). Bullets ( e )  indicate positions that are the same as  the 
human sequence. 
Variant or species cases or No' Of P10  P9  PS P I  P6  P5 P4 P3 P2 P1 
mecies 7f 8f  9f  10f l l f  12f  13f 14f 15f 16f 
Human-Lille I 
Human-Rouen  I 1 v 
Human-Zurich I"  14 * c  
Human-Manchester I* 26 * - - - * * - - H 
~~ ~ 























"Also Bergamo I, Geneva I, Hershey 11, Homberg I1 and 111, 
Kawaguchi I, Ledyard I, Leogan I, Metz I, Osaka I, Schwarzacb I, 
Stonybrook I, and Torino I. 
Also Amiens I and 11, Barcelona 11, Bergamo 111, Bern 11, Bicetre 
I, Birmingham I, Chapel Hill 11, Clermont-Ferrand I, Giessen I, 
Kendal I, Leitchfield I, Long Beach I, Louisville I, Milan VI, New 
Albany I, Paris VI, Petoskey I, Sapporo I, Seattle 11, Sheffield I, 
Stonybrook 11, Sydney 11, White  Marsh I. 
Also Japanese macaque, Rhesus monkey, red guenon, olive ba- 
boon, hamadryas baboon, gelada baboon, baboon, European bison, 
American elk, gray seal. 
dAlso sheep, goat, barbary sheep, domestic water buffalo, water 
buffalo, cape buffalo, Arabian camel, sika deer, European moose, 
llama, mule deer, gazelle,  pig, tapir. 
'' Also lion, cat, brown bear, fox. 
toward the active site. The serine residue was specifically 
assigned by Edman sequencing and amino acid analysis. How- 
ever, positions P8 to P2 were assigned by amino acid compo- 
sition  and homology with other fibrinopeptides (Mross  and 
Doolittle, 1967). Consequently, glycine could be at  P5 and  the 
threonine at P3 in the true sequence. The same argument 
pertains  to  the histidine at  P5 in  the lizard sequence which 
was also assigned only by amino acid compositions and ho- 
mology (Blomback and Blomback, 1968; Furlan, 1988). The 
sea lamprey fibrinogen A-chain, which has no residues after 
the P6 position, lacks the interactions with thrombin  contrib- 
uted by the residues in the helical turn of fibrinopeptide A, 
most especially the hydrophobic interactions of Phe-8f.  These 
drastic differences explain why  bovine thrombin  cannot re- 
lease lamprey fibrinopeptide A (Doolittle, 1965). 
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